-
1
-
-
0025286817
-
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
-
Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241.
-
(1990)
N Engl J Med
, vol.323
, pp. 236-241
-
-
Levine, B.1
Kalman, J.2
Mayer, L.3
Fillit, H.M.4
Packer, M.5
-
2
-
-
0032515950
-
-
Bozkurt B, Kribbs SB, Clubb FJ (jun), Michael LH, Didenko VV, Hornsby PJ, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97: 1382-1391.
-
Bozkurt B, Kribbs SB, Clubb FJ (jun), Michael LH, Didenko VV, Hornsby PJ, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97: 1382-1391.
-
-
-
-
3
-
-
0033749383
-
Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by antitumor necrosis factor alpha therapy
-
Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by antitumor necrosis factor alpha therapy. Proc Natl Acad Sci (USA) 2000; 97: 12746-12751.
-
(2000)
Proc Natl Acad Sci (USA)
, vol.97
, pp. 12746-12751
-
-
Li, Y.Y.1
Feng, Y.Q.2
Kadokami, T.3
McTiernan, C.F.4
Draviam, R.5
Watkins, S.C.6
-
4
-
-
0038755661
-
Anti-TNF Therapy Against Congestive Heart Failure investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
-
Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT, Anti-TNF Therapy Against Congestive Heart Failure investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003; 107: 3133-3140.
-
(2003)
Circulation
, vol.107
, pp. 3133-3140
-
-
Chung, E.S.1
Packer, M.2
Lo, K.H.3
Fasanmade, A.A.4
Willerson, J.T.5
-
5
-
-
0036888364
-
How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH
-
Anker SD, Coats AJ. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 2002; 86: 123-130.
-
(2002)
Int J Cardiol
, vol.86
, pp. 123-130
-
-
Anker, S.D.1
Coats, A.J.2
-
6
-
-
0032507428
-
Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy
-
Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 1998; 351: 1091-1093.
-
(1998)
Lancet
, vol.351
, pp. 1091-1093
-
-
Sliwa, K.1
Skudicky, D.2
Candy, G.3
Wisenbaugh, T.4
Sareli, P.5
-
7
-
-
18744426716
-
Polymorphisms of tumor necrosis factor-alpha and interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy
-
Ito M, Takahashi H, Fuse K, Hirono S, Washizuka T, Kato K, et al. Polymorphisms of tumor necrosis factor-alpha and interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy. Jpn Heart J 2000; 41: 183-191.
-
(2000)
Jpn Heart J
, vol.41
, pp. 183-191
-
-
Ito, M.1
Takahashi, H.2
Fuse, K.3
Hirono, S.4
Washizuka, T.5
Kato, K.6
-
8
-
-
0036156010
-
Tumour necrosis factor alpha gene polymorphism: A predisposing factor to non-ischaemic myocardial dysfunction?
-
Densem CG, Hutchinson IV, Yonan N, Brooks NH. Tumour necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction? Heart 2002; 87: 153-155.
-
(2002)
Heart
, vol.87
, pp. 153-155
-
-
Densem, C.G.1
Hutchinson, I.V.2
Yonan, N.3
Brooks, N.H.4
-
9
-
-
0030954180
-
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
-
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci (USA) 1997; 94: 3195-3199.
-
(1997)
Proc Natl Acad Sci (USA)
, vol.94
, pp. 3195-3199
-
-
Wilson, A.G.1
Symons, J.A.2
McDowell, T.L.3
McDevitt, H.O.4
Duff, G.W.5
-
10
-
-
7344251714
-
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
-
Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-406.
-
(1998)
Clin Exp Immunol
, vol.113
, pp. 401-406
-
-
Louis, E.1
Franchimont, D.2
Piron, A.3
Gevaert, Y.4
Schaaf-Lafontaine, N.5
Roland, S.6
-
11
-
-
0033614672
-
Endotoxin and immune activation in chronic heart failure: A prospective cohort study
-
Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353: 1838-1842.
-
(1999)
Lancet
, vol.353
, pp. 1838-1842
-
-
Niebauer, J.1
Volk, H.D.2
Kemp, M.3
Dominguez, M.4
Schumann, R.R.5
Rauchhaus, M.6
-
12
-
-
0032581020
-
Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial
-
Kubota T, McNamara DM, Wang JJ, Trost M, McTiernan CF, Mann DL, Feldman AM. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. Circulation 1998; 97: 2499-2501.
-
(1998)
Circulation
, vol.97
, pp. 2499-2501
-
-
Kubota, T.1
McNamara, D.M.2
Wang, J.J.3
Trost, M.4
McTiernan, C.F.5
Mann, D.L.6
Feldman, A.M.7
-
13
-
-
0017344976
-
Evaluation of ventricular function by radioisotopic techniques
-
Pitt B, Strauss HW. Evaluation of ventricular function by radioisotopic techniques. N Engl J Med 1977; 296: 1097-1099.
-
(1977)
N Engl J Med
, vol.296
, pp. 1097-1099
-
-
Pitt, B.1
Strauss, H.W.2
-
14
-
-
0021912472
-
Quantitative analysis of left ventricular function from equilibrium gated blood scintigrams: An overview of computer methods
-
Reiber JHC. Quantitative analysis of left ventricular function from equilibrium gated blood scintigrams: an overview of computer methods. Eur J Nucl Med 1985; 10: 97-110.
-
(1985)
Eur J Nucl Med
, vol.10
, pp. 97-110
-
-
Reiber, J.H.C.1
-
15
-
-
0018231715
-
The committee on Mmode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements
-
Sahn DJ, de Maria A, Kisslo J, Weyman A. The committee on Mmode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
-
(1978)
Circulation
, vol.58
, pp. 1072-1083
-
-
Sahn, D.J.1
de Maria, A.2
Kisslo, J.3
Weyman, A.4
-
16
-
-
0002193833
-
Rapid and efficient DNA extraction for PCR from cells or blood
-
Higuchi R. Rapid and efficient DNA extraction for PCR from cells or blood. Amplifications 1989; 2: 2-3.
-
(1989)
Amplifications
, vol.2
, pp. 2-3
-
-
Higuchi, R.1
-
17
-
-
33745602762
-
Systemic inflammation in heart failure - the whys and wherefores
-
Yndestad A, Damås JK, Oie E, Ueland T, Gullestad L, Aukrust P. Systemic inflammation in heart failure - the whys and wherefores. Heart Fail Rev 2006; 11: 83-92.
-
(2006)
Heart Fail Rev
, vol.11
, pp. 83-92
-
-
Yndestad, A.1
Damås, J.K.2
Oie, E.3
Ueland, T.4
Gullestad, L.5
Aukrust, P.6
-
18
-
-
0033958697
-
Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: The CARDIGENE study
-
Tiret L, Mallet C, Poirier O, Nicaud V, Millaire A, Bouhour JB, et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 2000; 35: 29-35.
-
(2000)
J Am Coll Cardiol
, vol.35
, pp. 29-35
-
-
Tiret, L.1
Mallet, C.2
Poirier, O.3
Nicaud, V.4
Millaire, A.5
Bouhour, J.B.6
-
19
-
-
0033081764
-
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
-
Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 376-382.
-
(1999)
Am J Cardiol
, vol.83
, pp. 376-382
-
-
Aukrust, P.1
Ueland, T.2
Lien, E.3
Bendtzen, K.4
Muller, F.5
Andreassen, A.K.6
-
20
-
-
0033958697
-
Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: The CARDIGENE study
-
Fujioka S, Kitaura Y, Deguchi H, Shimizu A, Isomura T, Suma H, Sabbah HN. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 2000; 35: 29-35.
-
(2000)
J Am Coll Cardiol
, vol.35
, pp. 29-35
-
-
Fujioka, S.1
Kitaura, Y.2
Deguchi, H.3
Shimizu, A.4
Isomura, T.5
Suma, H.6
Sabbah, H.N.7
-
21
-
-
0025913812
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
-
The SOLVD investigators
-
The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med 1991; 325: 293-302.
-
(1991)
New Engl J Med
, vol.325
, pp. 293-302
-
-
|